Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.43 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.40 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.40 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13531823 | 1.00 | FAAH (0.47) | FAAHGPR119TPSAB1TPSD1TPSG1 | |
| SCHEMBL3170660 | 1.00 | FAAH (0.47) | FAAHGPR119TPSAB1TPSD1TPSG1 | |
| SCHEMBL3190011 | 0.86 | FAAH (0.41) | FAAHGPR119TPSAB1TPSD1TPSG1 | |
| SCHEMBL13531822 | 0.86 | FAAH (0.41) | FAAHGPR119TPSAB1TPSD1TPSG1 | |
| SCHEMBL3190005 | 0.86 | FAAH (0.41) | FAAHGPR119TPSAB1TPSD1TPSG1 | |
| SCHEMBL1721025 | 0.81 | FAAH (0.52) | FAAHGPR119TPSAB1TPSD1TPSG1 | |
| SCHEMBL3179102 | 0.80 | GPR119 (0.51) | FAAHGPR119GAA | |
| SCHEMBL459688 | 0.78 | FAAH (0.51) | FAAHGPR119 | |
| SCHEMBL14116719 | 0.78 | FAAH (0.51) | FAAHGPR119 | |
| SCHEMBL3180540 | 0.77 | FAAH (0.54) | FAAHGPR119TPSAB1TPSD1TPSG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022515-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY | IRM LLC (BM) | 2010-01-28 | — | — | US | disclosed |
| EP-2114890-A2 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY | IRM LLC (BM) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008097428-A2 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY | IRM LLC (BM) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022515-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY | GPR119, GCGR, GPR65 | FAAH 814/4885GPR119 1/4885TPSAB1 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.